Advertisement
Advertisement

ARVN

ARVN logo

Arvinas, Inc

9.87
USD
Sponsored
+0.30
+3.13%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

10.01

+0.14
+1.44%

Arvinas, Inc Profile

About

Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.

Info & Links

CEO

Randy Teel

Headquarters

5 SCIENCE PARK, 395 WINCHESTER AVENUE
NEW HAVEN, CT 06511, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.arvinas.com

Auditor

Deloitte & Touche LLP

Share holders

18

Employees

246

Arvinas, Inc Statistics

Valuation Measures

Market Capitalization2

645.95M

Enterprise Value

558.95M

Enterprise Value/EBITDA(ttm)

-2.17

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.72

Price to Book(mrq)

1.65

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-30.77%

Profit Margin(ttm)

-255.64%

Return on Equity(ttm)

-14.25%

Return on Invested Capital(ttm)

-19.22%

Return on Assets(ttm)

-9.31%

Income Statement

Revenue(ttm)

89.40M

Revenue Per Share(ttm)

1.39

Gross Profit(ttm)

89.40M

EBITDA(ttm)3

-258.10M

Net Income Available to Common(ttm)

-221.30M

Diluted EPS(ttm)

-1.28

Share Statistics

Beta (5Y Monthly)

1.97

52-Week Change

56.92%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

64.52M

Dividend Yield

0.00%

Float4

60.94M

% Held by Insiders

4.73%

% Held by Institutions

95.19%

Balance Sheet

Total Cash(mrq)

614.90M

Total Cash Per Share(mrq)

9.53

Total Debt(mrq)

300.00K

Total Debt/Equity(mrq)

0.09%

Current Ratio(mrq)

4.92%

Quick Ratio(mrq)

4.92%

Book Value Per Share(mrq)

6.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.86

Free Cash Flow(ytd)

-275.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement